MedPath

Belpharma Sa

🇧🇪Belgium
Ownership
Private
Employees
-
Market Cap
-
Website

Temocillin Use in Complicated Urinary Tract Infections Due to Extended Spectrum Beta-Lactamases (ESBL)/AmpC Enterobacteriaceae

Phase 4
Withdrawn
Conditions
Urinary Tract Infection
Interventions
First Posted Date
2012-03-05
Last Posted Date
2013-01-29
Lead Sponsor
Belpharma s.a.
Registration Number
NCT01543347
Locations
🇬🇧

Birmingham Heartlands Hospital, Birmingham, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath